-
-
-
-
-
-
-
Truist Reiterates Buy Rating on Perspective Therapeutics Inc (CATX)
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $13 at Oppenheimer
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $14 at Oppenheimer
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $15 at Oppenheimer
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $16 at RBC Capital
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Perspective Therapeutics Inc (CATX)
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Raised to $19 at Oppenheimer
-
435,212 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

